Evidence map›Paper›PMID 41254766›Full record

ArticleJournal of translational medicine2025

Spatial profiling of HPV-stratified head and neck squamous cell carcinoma reveals distinct immune niches and microenvironmental architectures.

Ettai Markovits, Dmytro Klymyshyn, Roni Froumine, Hailing Zong, Michael Mints, Sangeetha Mahadevan, Kenneth Bloom, Jamie Bates, Gareth J Thomas, Lauri Diehl and 2 more

Abstract read
In one paragraph

Article in Journal of translational medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Targeting innate immunity to overcome immune evasion in HPV-associated cancers.Frontiers in cellular and infection microbiology · 2026
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Ettai MarkovitsNucleai, Tel Aviv, Israel. ettai.markovits@nucleai.ai.
Dmytro KlymyshynGilead Sciences Inc., Foster City, CA, USA.
Roni FroumineNucleai, Tel Aviv, Israel.
Hailing ZongGilead Sciences Inc., Foster City, CA, USA.
Michael MintsNucleai, Tel Aviv, Israel.
Sangeetha MahadevanGilead Sciences Inc., Foster City, CA, USA.
Kenneth BloomNucleai, Tel Aviv, Israel.
Jamie BatesGilead Sciences Inc., Foster City, CA, USA.
Gareth J ThomasUniversity of Southampton, Southampton, UK.
Lauri DiehlGilead Sciences Inc., Foster City, CA, USA.
Oscar PuigNucleai, Tel Aviv, Israel.
Abhishek AggarwalGilead Sciences Inc., Foster City, CA, USA. abhishek.aggarwal5@gilead.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundHPV status is a key determinant of prognosis and treatment response in head and neck squamous cell carcinoma (HNSCC). To investigate how HPV influences the tumor-immune-stromal landscape, we performed high-dimensional spatial profiling, including its impact on spatial organization, tertiary lymphoid structures (TLSs), and spatially organized cellular neighborhoods.

methodsTumor biopsies from HNSCC patients (n = 16; 7 HPV-positive, 9 HPV-negative) were stained with a multiplex immunofluorescence (mIF) panel focused on immune profiling. A deep learning-based analysis pipeline enabled the identification and phenotypic state profiling of 14 cell types. Tissues were segmented into four distinct tumor regions, and spatial neighborhoods and TLSs were identified and analyzed for differential cellular composition, activation states, and spatial interactions between HPV-positive and HPV-negative tumors.

resultsHPV-positive and HPV-negative tumors differ in their tumor microenvironment (TME) composition, tumor cell state and spatial organization. The TME of HPV-positive tumors exhibited a greater abundance of activated lymphocytes, B- and T-cell-enriched spatial neighborhoods, and PD-1-PD-L1 interactions within the tumor area, whereas HPV-negative tumors were dominated by fibroblast- and macrophage-rich niches. T- cells in HPV-positive tumors showed greater activation across neighborhoods and areas, while in HPV-negative tumors T- cells demonstrated enrichment of exhaustion and terminal differentiation markers such as PD-1 and CD57. HPV-positive tumor cells had increased IDO1, HLA-DR, and Ki67 positivity, whereas HPV-negative tumor cells were more frequently CD44 positive, reflecting a more stem-like phenotype. Importantly, TLSs in HPV-positive tumors were located closer to the tumor area and enriched in activated immune cells, including ICOS

conclusionsHPV status defines distinct spatial immune architectures in HNSCC. HPV-positive tumors harbor immune-activating TLSs and cellular neighborhoods that support antitumor immunity, whereas HPV-negative tumors exhibit suppressive niches and stromal dominance. These findings highlight TLSs, particularly their proximity and composition, as key features of the HPV-stratified TME and potential biomarkers for immunotherapy response.

Indexed as

Head and Neck NeoplasmsPapillomaviridaePapillomavirus InfectionsSquamous Cell Carcinoma of Head and NeckTumor MicroenvironmentAgedFemaleHumansLymphocytes, Tumor-InfiltratingMaleMiddle AgedTertiary Lymphoid Structures

Identifiers

PMID41254766
PMCPMC12625076

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.